Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Open-market buy Director bought 1,212,122 shares at $3.30 ($4,000,003)
  2. 4/A Open-market sale Chief Accounting Officer sold 1,129 shares at $15.89 ($17,940)
  3. 4 Open-market sale Chief Accounting Officer sold 2,802 shares at $16.02 ($44,888)
  4. 4 Insider Changes in Ownership
  5. 4 Open-market buy Director bought 20,000 shares at an average $13.21 ($264,289)
  6. 4 Derivatives Options or other derivatives
  7. 4 Shares withheld for taxes Chief Accounting Officer gave up 759 shares (to pay taxes)
  8. 4 Open-market sale 10% owner sold 32,005,260 shares at $12.25 ($392,064,435)
  9. 4 Grant or award Director acquired 17,482 shares (grant or award)
  10. 4 Grant or award Director acquired 17,482 shares (grant or award)
  11. 4 Grant or award Director acquired 17,482 shares (grant or award)
  12. 4 Grant or award Director acquired 17,482 shares (grant or award)
  13. 4 Grant or award Director acquired 17,482 shares (grant or award)
  14. 4 Grant or award Director acquired 17,482 shares (grant or award)
  15. 4 Insider Changes in Ownership
  16. 4 Grant or award Chief Accounting Officer acquired 10,305 shares (grant or award)
  17. 4 Grant or award Director acquired 1,612 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Director bought 4,285,935 shares at $3.25 ($13,929,289)
  20. 3 Insider Initial Statement of Ownership

Page 6 of 39 · 776 filings